Herbas VPB

Print
EN | LT
LT - Pirazolo junginiai, kaip CRTH2 antagonistai
EN - PYRAZOLE COMPOUNDS AS CRTH2 ANTAGONISTS

Legal status

Patent lapsed (non-payment of fees)

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07D 403/12 (2006.01)
C07D 407/12 (2006.01)
C07D 409/12 (2006.01)
A61K 31/4155 (2006.01)
A61P 29/00 (2006.01)
European patent
(11) Number of the document 2668181
(13) Kind of document T
(96) European patent application number 12700695.5
Date of filing the European patent application 2012-01-20
(97) Date of publication of the European application 2013-12-04
(45) Date of publication and mention of the grant of the patent 2014-11-05
(46) Date of publication of the claims translation 2015-02-25
PCT application
(86) Number PCT/EP2012/050830
Date 2012-01-20
PCT application publication
(87) Number WO 2012/101043
Date 2012-08-02
Priority applications
(30) Number Date Country code
11151876 2011-01-24 EP
Inventors
(72)
ANDERSKEWITZ, Ralf, DE
MARTYRES, Domnic, DE
OOST, Thorsten, DE
RIST, Wolfgang, DE
SEITHER, Peter, DE
Grantee
(73) GB007, Inc., 3013 Science Park Road, Suite 200, San Diego, CA 92121, US
Attorney or representative
(74) Reda ŽABOLIENĖ, METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius, LT
Title
(54) Pirazolo junginiai, kaip CRTH2 antagonistai
  PYRAZOLE COMPOUNDS AS CRTH2 ANTAGONISTS
Last renewal fee
Payment date Validity (years) Amount
2019-12-31 9 208.00 EUR
Legal status
Patent lapsed (non-payment of fees)
Invalidation date 2021-01-20